Skip to main content
Livermore
Livermore
ZHEN

Geode Capital Management, LLC

SEC CIK
0001214717
Latest filing
Aug 12, 2026

TNXP holding history

Tonix Pharmaceuticals Holding Corp. in every 13F filed by Geode Capital Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TNXP overviewAll 13F holders of TNXPFull Q2 2026 holdings

Shares (Q2 2026)
395,260
Value
$5.04M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of TNXP by Geode Capital Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026395,260$5.04M<0.1%+81,969+26.2%AddedHolders
Q1 2026313,291$4.31M<0.1%+41,387+15.2%AddedHolders
Q4 2025271,904$4.25M<0.1%+70,970+35.3%AddedHolders
Q3 2025200,934$4.86M<0.1%+25,722+14.7%AddedHolders
Q2 2025175,212$6.31M<0.1%+113,175+182.4%AddedHolders
Q1 202562,037$1.11M<0.1%−1,909,857−96.9%ReducedHolders
Q4 20241,971,894$650.3K<0.1%+1,855,907+1,600.1%AddedHolders
Q3 2024115,987$17.2K<0.1%+99,441+601.0%AddedHolders
Q2 202416,546$11.5K<0.1%−382,160−95.9%ReducedHolders
Q1 2024398,706$74.2K<0.1%+292,095+274.0%AddedHolders
Q4 2023106,611$43.0K<0.1%−19,686−15.6%ReducedHolders
Q3 2023126,297$68.8K<0.1%+40,932+47.9%AddedHolders
Q2 202385,365$134.9K<0.1%00.0%UnchangedConverted for a 4-for-25 splitHolders
Q1 2023533,511$315.4K<0.1%+161,659+43.5%AddedHolders
Q4 2022371,852$144.0K<0.1%+27,892+8.1%AddedHolders
Q3 2022343,960$183.0K<0.1%+211,110+158.9%AddedHolders
Q2 2022132,850$209.0K<0.1%−7,482,408−98.3%ReducedHolders
Q1 20227,615,258$1.75M<0.1%+414,647+5.8%AddedHolders
Q4 20217,200,611$2.58M<0.1%−222,715−3.0%ReducedHolders
Q3 20217,423,326$4.46M<0.1%+1,901,592+34.4%AddedHolders
Q2 20215,521,734$6.13M<0.1%+2,625,017+90.6%AddedHolders
Q1 20212,896,717$3.71M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.